Plain-English translation of NCT04572256 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
After ACL reconstruction surgery, many patients develop arthritis in the knee within 10–15 years, even though their pain may feel better. This trial tests whether taking — a medication that reduces inflammation — for 6 months after surgery can slow down the cartilage damage that happens silently over time. Researchers will compare patients who take this medication to those who take a placebo pill to see if the treatment helps protect the knee.
After ACL surgery, the knee joint goes through a damaging inflammatory cascade that breaks down cartilage without causing pain or obvious symptoms — making it hard to catch and treat early. This study aims to see whether reducing that inflammation with medication right after surgery can prevent or slow down long-term arthritis development.
You likely qualify if…
You likely don't qualify if…
You will undergo standard ACL reconstruction surgery. Starting after surgery, you will take either the study medication or a placebo pill once daily for 6 months. You will return for follow-up visits where doctors will monitor your knee recovery, ask about your symptoms, and likely perform imaging or fluid tests to track cartilage health over time.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States